Go to:
Logótipo
Você está em: Start > Publications > View > Time-saved and time-invested with anti-amyloid treatments in early Alzheimer's disease: practical considerations
Publication

Time-saved and time-invested with anti-amyloid treatments in early Alzheimer's disease: practical considerations

Title
Time-saved and time-invested with anti-amyloid treatments in early Alzheimer's disease: practical considerations
Type
Another Publication in an International Scientific Journal
Year
2025
Authors
Araújo, R
(Author)
FMUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Carneiro, DR
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Rato, RN
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Massano, J
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Journal
The Journal is awaiting validation by the Administrative Services.
ISSN: 0967-5868
Indexing
Publicação em ISI Web of Knowledge ISI Web of Knowledge - 0 Citations
Publicação em Scopus Scopus - 0 Citations
Other information
Authenticus ID: P-019-YXW
Resumo (PT):
Abstract (EN): Anti-amyloid treatments for early Alzheimer's disease very effectively remove amyloid deposits from the brain and have shown an approximately 30 % less worsening in cognitive functions compared to placebo. Some additional metrics, such as time-saved, i.e. the additional time people may live independently, have been suggested to better inform patients and the general public about the benefits and risks of these medications. Some authors report 4-6 months, and others 10-13 months, depending on the treatment period, time of follow-up, and the methodology used. Taking into consideration that these drugs' regimens are monthly or bi-weekly intravenous infusions requiring clinical supervision, and the necessary brain MRIs for follow-up, we argue that the time spent travelling by the patients and their family members should also be taken into consideration when proposing anti-amyloid treatments, and specifically, when discussing the amount of time saved. In this study, we report that nearly half of the possible eligible patients for anti-amyloid treatments experience a reduction in motivation after receiving the information about the number of times required to come to the hospital, especially those travelling long distances (average time: 60 min for one-way). We propose a rough estimate for the additional time patients and their family members are likely to spend in these arrangements and suggest these additional calculations should be part of the decision-making process.
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 4
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same journal

Early deep brain stimulation in patients with myoclonus-dystonia syndrome (2016)
Another Publication in an International Scientific Journal
Paulo Linhares
Two- versus multi-rod constructs for adult spinal deformity: A systematic review and Random-effects and Bayesian meta-analysis (2023)
Article in International Scientific Journal
Moniz-Garcia, D; Stoloff, D; Akinduro, O; De Biase, G; Sousa-Pinto, B; Beeler, C; Elder, BD; Buchanan, I; Abode-Iyamah, K
Tumoriform presentation of cerebral candidiasis in an HIV-infected patient (2009)
Article in International Scientific Journal
Mendes, V; Castro, S; Linhares, P; Ribeiro Silva, ML
Transcranial Doppler-derived indices of cerebrovascular haemodynamics are independent of depth and angle of insonation (2020)
Article in International Scientific Journal
Heckelmann, M; Shivapathasundram, G; Cardim, D; Smielewski, P; Czosnyka, M; Rita Gaio; Sheridan, MMP; Jaeger, M
Post cerebral venous thrombosis headache - Prevalence, mechanisms and risk factors (2024)
Article in International Scientific Journal
Dias, L; Pinto, MJ; Maia, R; Albuquerque, L; Marta Carvalho

See all (6)

Recommend this page Top
Copyright 1996-2026 © Faculdade de Farmácia da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2026-04-18 at 21:02:11 | Privacy Policy | Personal Data Protection Policy | Whistleblowing | Electronic Yellow Book